Boundless Bio, Inc. Common Stock (BOLD NASDAQ) stock market data APIs
$1.0481
0.02(1.9%)
as of February 4, 2026
Try our APIs with
free plan!
Boundless Bio, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Prev. Close
1.0481
Open
1.0707
High
1.1107
Low
1.0348
52 wk Range
1-2.48
Market Cap
23 505 K
Shares Outstanding
22 386 K
EPS
-0.62
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Boundless Bio, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Boundless Bio, Inc. Common Stock data using free add-ons & libraries
Get Boundless Bio, Inc. Common Stock Fundamental Data
Boundless Bio, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -66 588 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -1.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Boundless Bio, Inc. Common Stock News
New
Bitcoin and Gold ETF (BOLD) From 21Shares Goes Live on London Stock Exchange
On January 13, 21Shares launched its Bitcoin and Gold ETF (BOLD), which began trading on the London Stock Exchange. This offers investors a regulated vehicle, offering exposure to both physical gold ...
21Shares Lists Bitcoin-and-Gold ‘BOLD’ ETP on London Stock Exchange
Switzerland-based investment product provider 21Shares has listed its Bitcoin and Gold exchange-traded product (ETP), BOLD, on the London Stock Exchange, marking the first product on the venue to comb...
21shares launches BOLD ETP combining bitcoin and gold in a single regulated product
Approved by Archax 12/01/2026 Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wron...
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to...
Get Boundless Bio, Inc. Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
